Literature DB >> 12810650

Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.

Tina L Tinley1, Deborah A Randall-Hlubek, Rachel M Leal, Evelyn M Jackson, James W Cessac, James C Quada, Thomas K Hemscheidt, Susan L Mooberry.   

Abstract

During the course of a mechanism-based screening program designed to identify new microtubule-disrupting agents from natural products, we identified a crude extract from Tacca chantrieri that initiated Taxol-like microtubule bundling. Bioassay-directed purification of the extract yielded the highly oxygenated steroids taccalonolides E and A. The taccalonolides caused an increased density of cellular microtubules in interphase cells and the formation of thick bundles of microtubules similar to the effects of Taxol. Mitotic cells exhibited abnormal mitotic spindles containing three or more spindle poles. The taccalonolides were evaluated for antiproliferative effects in drug-sensitive and multidrug-resistant cell lines. The data indicate that taccalonolide E is slightly more potent than taccalonolide A in drug-sensitive cell lines and that both taccalonolides are effective inhibitors of cell proliferation. Both taccalonolides are poorer substrates for transport by P-glycoprotein than Taxol. The ability of the taccalonolides to circumvent mutations in the Taxol-binding region of beta-tubulin was examined using the PTX 10, PTX 22, and 1A9/A8 cell lines. The data suggest little cross-resistance of taccalonolide A as compared with Taxol, however, the data from the PTX 22 cell line indicate a 12-fold resistance to taccalonolide E, suggesting a potential overlap of binding sites. Characteristic of agents that disrupt microtubules, the taccalonolides caused G(2)-M accumulation, Bcl-2 phosphorylation, and initiation of apoptosis. The taccalonolides represent a novel class of plant-derived microtubule-stabilizers that differ structurally and biologically from other classes of microtubule-stabilizers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810650

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Polygamain, a new microtubule depolymerizing agent that occupies a unique pharmacophore in the colchicine site.

Authors:  R M Hartley; J Peng; G A Fest; S Dakshanamurthy; D E Frantz; M L Brown; S L Mooberry
Journal:  Mol Pharmacol       Date:  2011-12-14       Impact factor: 4.436

2.  Texas Native Plants Yield Compounds with Cytotoxic Activities against Prostate Cancer Cells.

Authors:  Corena V Shaffer; Shengxin Cai; Jiangnan Peng; Andrew J Robles; Rachel M Hartley; Douglas R Powell; Lin Du; Robert H Cichewicz; Susan L Mooberry
Journal:  J Nat Prod       Date:  2016-01-19       Impact factor: 4.050

3.  Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin.

Authors:  Rundi Ma; Gang Song; Wenbing You; Lijian Yu; Weiming Su; Mingneng Liao; Yongping Zhang; Laizhen Huang; Xiaoyu Zhang; Tingxi Yu
Journal:  Cancer Chemother Pharmacol       Date:  2007-11-21       Impact factor: 3.333

4.  Design, synthesis, and biological evaluations of 2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoline analogs of combretastatin-A4.

Authors:  Lauren Lee; Lyda M Robb; Megan Lee; Ryan Davis; Hilary Mackay; Sameer Chavda; Balaji Babu; Erin L O'Brien; April L Risinger; Susan L Mooberry; Moses Lee
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

Review 5.  Taccalonolides: Novel microtubule stabilizers with clinical potential.

Authors:  April L Risinger; Susan L Mooberry
Journal:  Cancer Lett       Date:  2009-10-31       Impact factor: 8.679

Review 6.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

7.  Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.

Authors:  A L Risinger; J Li; M J Bennett; C C Rohena; J Peng; D C Schriemer; S L Mooberry
Journal:  Cancer Res       Date:  2013-09-18       Impact factor: 12.701

8.  A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agent.

Authors:  Yali Kong; Kan Wang; Michael C Edler; Ernest Hamel; Susan L Mooberry; Mikell A Paige; Milton L Brown
Journal:  Bioorg Med Chem       Date:  2009-11-10       Impact factor: 3.641

9.  Function-oriented synthesis: biological evaluation of laulimalide analogues derived from a last step cross metathesis diversification strategy.

Authors:  Susan L Mooberry; Michael K Hilinski; Erin A Clark; Paul A Wender
Journal:  Mol Pharm       Date:  2008-07-29       Impact factor: 4.939

Review 10.  Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.

Authors:  John H Miller; A Jonathan Singh; Peter T Northcote
Journal:  Mar Drugs       Date:  2010-03-31       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.